benign prostatic hypertrophy


Also found in: Dictionary, Thesaurus, Acronyms, Encyclopedia.

hypertrophy

 [hi-per´tro-fe]
increase in volume of a tissue or organ produced entirely by enlargement of existing cells. See also hyperplasia and proliferation. adj., adj hypertro´phic.
asymmetrical septal hypertrophy
2. the term is sometimes limited to cases of hypertrophic cardiomyopathy in which the hypertrophy is localized to the interventricular septum. See also hypertrophic obstructive cardiomyopathy.
benign prostatic hypertrophy (BPH) age-associated enlargement of the prostate resulting from proliferation of glandular and stromal elements, beginning generally in the fifth decade of life; it may cause urethral compression and obstruction. Called also benign prostatic hyperplasia and nodular hyperplasia of the prostate.
cardiac hypertrophy enlargement of myocardial cells and hyperplasia of nonmuscular cardiac components due to pressure and volume overload and sometimes to neurohumoral factors.
compensatory hypertrophy that which results from an increased workload due to some physical defect, such as in an organ where one part is defective, or in one kidney when the other is absent or nonfunctional.
functional hypertrophy hypertrophy of an organ or part caused by its increased activity.
ventricular hypertrophy hypertrophy of the myocardium of a ventricle, due to chronic pressure overload; it is manifest electrocardiographically by increased QRS complex voltage, frequently accompanied by repolarization changes.

be·nign pros·tat·ic hy·per·tro·phy

erroneous term; mistakenly used as a synonym of nodular hyperplasia of prostate.

benign prostatic hypertrophy

benign prostatic hyperplasia

Benign enlargement of the prostate, which is normal after age 50 and secondary to androgen and related hormones; BPH pushes against the urethra, blocking urine flow.
 
Clinical findings
Bladder-outlet obstruction, seen in 50% of men ≥ age 60; excess enlargement may obstruct the urethra, causing urinary retention; 30+% require surgery.

benign prostatic hypertrophy

Benign prostatic hyperplasia Urology A benign enlargement of the prostate, which is normal after age 50, 2º to ♂ hormones; BPH pushes against the urethra and the bladder, blocking urine flow Clinical Bladder-outlet obstruction, seen in 50% of ♂ ≥ age 60; excess enlargement may obstruct the urethra, causing urinary retention; 30+% require surgery. See Finasteride, TURP, Urinary retention.

be·nign pros·tat·ic hy·per·tro·phy

(BPH) (bē-nīn pros-tatik hī-pĕrtrŏ-fē)
Erroneous term; mistakenly used as a synonym of nodular hyperplasia of prostate

Benign prostatic hypertrophy (BPH)

Benign prostatic hypertrophy is an enlargement of the prostate that is not cancerous. However, it may cause problems with urinating or other symptoms.
Mentioned in: Prostate Ultrasound
References in periodicals archive ?
Synaptic has been issued United States patents covering the alpha-1a adrenergic receptor and the use of selective alpha-1a antagonists for the treatment of benign prostatic hypertrophy.
Ozarelix, a luteinizing hormone-releasing hormone (LHRH) antagonist, was in late stage trials for the treatment of benign prostatic hypertrophy.
Clinical evaluation of Cernilton in benign prostatic hypertrophy.
The most common conditions include prostatitis--inflammation of the prostate --which can cause pain and can interfere with urination and sexual functioning, and benign prostatic hypertrophy (BPH)--enlargement of the prostate--which causes frequent urination, but does not impair sexual function.
Tokyo, Japan, Jan 24, 2006 - (JCN) - Kissei Pharmaceutical announced on January 23 that it has received approval from the Ministry of Health, Labor and Welfare to manufacture URIEF Capsule 2mg/4mg, its proprietary agent for treating benign prostatic hypertrophy (BPH).
Also, reviews of herbal therapies have concluded that garlic has utility in atherosclerosis of the lower limbs and that saw palmetto is useful for benign prostatic hypertrophy.
This molecule is not converted into dihydrotestosterone, which may limit the occurrence of acne, baldness, and benign prostatic hypertrophy.
In addition, 35 men will not develop benign prostatic hypertrophy, 27 will have less urinary urgency or frequency, and 21 will report less urinary retention.
This has become the most important herb in treating benign prostatic hypertrophy.
Men experience a high probability of prostate health problems as they grow older, including benign prostatic hypertrophy (BPH), prostatic intraepithelial neoplasia--a putative precursor for cancer--and prostate cancer.
There is consistent evidence that a daily dose of 320 mg of saw palmetto can help men with benign prostatic hypertrophy (enlarged prostates).

Full browser ?